Global private equity and venture capital news and research

Hony Capital eyes up to $535m in further offload of CSPC Pharma shares

28 Aug 2014

yellow-pills-755962-mChinese private equity firm Hony Capital is reportedly set to sell $500m of shares in CSPC Pharmaceutical Group for the second time in three months.

Hony is offering 650 million shares in CSPC, according to a term sheet seen by IFR, in a bid to cash in on the drug company’s buoyant stock.

The firm has set a range of HK$6.30 ($0.81) to HK$6.45 per share which means the it could raise up to $535m.

Hony raised $569m selling shares of CPSC in May this year.

CPSC makes drugs to treat strokes and different types of cancer, as producing vitamin C, caffeine and antibiotics.

Goldman Sachs, Morgan Stanley and UBS are joint bookrunners of the sale, said IFR.

Last October Hony was looking to make about $260m by selling shares in CSPC Pharmaceutical Group through two affiliates.

Jinling Investment and Joyful Horizon were offering 500 million shares in the Chinese vitamin maker.

Copyright © 2014 AltAssets

AltAssets Mobile App

To access the latest private equity news and stories download the new AltAssets mobile app from the

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015